This initial dose is specifically designed as a starting dose rather than a therapeutic maintenance dose, serving primarily to help the body adjust to the medication and minimise potential gastrointestinal side effects
Gastrointestinal Adverse Reactions In the pool of placebo-controlled trials, gastrointestinal adverse reactions occurred more frequently among patients who received semaglutide tablets than placebo: semaglutide tablets 14 mg once daily (41%), semaglutide tablets 7 mg once daily (32%) and placebo (21%), including severe reactions (semaglutide tablets 14 mg 2.0%, semaglutide tablets 7 mg 0.6%, placebo 0.3%)
Bananas have a glycemic index (GI) of approximately 51 (medium ripeness) according to international GI databases, classifying them as a low-to-medium GI food
The service accepts most major insurance plans, which can help reduce out-of-pocket costs for eligible patients
Higher concentrations may degrade differently than lower ones